Rainbow Children's Medicare aims to sustain 27% growth, plans 350-bed expansion: Abrarali Dalal
NiveshIQ
NSE: RAINBOW · Healthcare
Rainbow Childrens Medicare Ltd.
₹1,239.20▲ ₹20.50 (+1.68%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on RAINBOW. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Rainbow Childrens Medicare Ltd.
Rainbow Children’s Medicare Limited operates a multi‑specialty pediatric, obstetrics and gynecology hospital chain headquartered in Hyderabad, offering services under the Rainbow Children’s Hospital and Birthright brands. The core revenue drivers are inpatient care, intensive care units, and complex procedures such as multi‑organ transplantation, alongside perinatal and fertility services. In Q2 FY27, the company reported a 23.21% year‑on‑year revenue rise to ₹550 cr and net profit of ₹83.89 cr, driven by the opening of new units in Nellore and Guntur and ongoing expansion plans in Malad. The firm’s competitive position is strengthened by its niche focus on pediatric and women’s health, a dedicated DNB training program, and a growing network of high‑volume specialty hospitals. Analysts pro
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹1,297 Cr +10.51% | ₹1,516 Cr +16.88% | ₹1,703 Cr +12.35% |
| EBITDA Margin | 33.07% | 32.32% | 31.95% |
| Net Profit | ₹217.00 Cr +2.93% | ₹243.42 Cr +12.18% | ₹278.32 Cr +14.34% |
| EPS | ₹21.38 | ₹23.97 | ₹27.41 |
Annual figures in Indian Rupees (Crores). Source: company filings (NSE).
Recent News
Rainbow Children’s Q2 FY27 slides: 23% revenue growth amid margin pressure By Investing.com
Earnings call transcript: Rainbow Children’s Medicare misses Q2 2026 EPS forecast By Investing.com
🔒
+ 3 more stories about Rainbow Childrens Medicare Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q2FY27 results: revenue ₹487 Cr, PAT ₹75 Cr, EPS ₹7.41, EBITDA margin 31.1%. Growth context: revenue YoY +9.5%, PAT YoY -0.2%, revenue QoQ +3.6%, PAT QoQ +24.0%.
Management highlights new capacity addition, capex deployment, order wins, deal pipeline and backlog build as the primar...
FY26 (last completed FY): revenue ₹1, 703 Cr, PAT ₹278 Cr, EBITDA margin 32.0%, EPS ₹27.41. Year-on-year: revenue YoY +1...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantMore Healthcare stocks
Everything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for RAINBOW
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track RAINBOW alongside your other holdings
Unlock full RAINBOW research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Rainbow Childrens Medicare Ltd.?
NiveshIQ detects active intelligence signals for Rainbow Childrens Medicare Ltd. (RAINBOW) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Rainbow Childrens Medicare Ltd.?
Rainbow Childrens Medicare Ltd. operates in the Healthcare sector with a market capitalisation of ₹1,321,764.4L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.